Viral pathogenesis of hepatocellular carcinoma in the United States

Hepatology

Volumn 18, Issue 6, 1993, Pages 1326-1333

  Liang, T Jake ^a,c   Jeffers, Lennox J ^b   Reddy, K Rajender ^b   De Medina, Maria ^b   Parker, I Talley ^b   Cheinquer, Hugo ^b   Idrovo, Victor ^b   Rabassa, Alfredo ^b   Schiff, Eugene R ^b  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; VIRUS DNA; VIRUS RNA;

ADULT; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA ANALYSIS; SEROLOGY; UNITED STATES; VIRUS DETECTION; VIRUS HEPATITIS;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; DNA, VIRAL; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; IMMUNOBLOTTING; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGE; POLYMERASE CHAIN REACTION; PREVALENCE; RNA, VIRAL; SUPPORT, U.S. GOV'T, P.H.S.; UNITED STATES;

EID: 0027490712     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.1840180607     Document Type: Article

References (56)

1. Hepatocellular carcinoma
2. Hepatocellular carcinoma in the world: Epidemiologic questions
3. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen
4. Hepatitis B viral nucleotide sequences in non‐A, non‐B hepatitis B virus–related chronic liver disease
5. Identification and transmission of hepatitis B virus–related variant
6. Rapid identification of low level hepatitis B related viral genome in serum
7. Detection and cloning by the polymerase chain reaction of hepatitis B virus (HBV) DNA sequences in blood samples negative for HBV serologic markers
8. Detection of serum hepatitis B virus DNA using the polymerase chain reaction assay
9. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis
10. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma
11. Hepatitis B and C viral infections in patients with hepatocellular carcinoma
12. Hepatitis C virus antibodies in Southern African Blacks with hepatocellular carcinoma
13. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma
14. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population
15. Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States
16. Chronic viral hepatitis and hepatocellular carcinoma in the United States
17. Hepatitis C–associated hepatocellular carcinoma
18. Fulminant or sub‐fulminant non‐A, non‐B viral hepatitis: the role of hepatitis C and E viruses
19. Characterization and biological properties of a hepatitis B virus isolated from a patient without HBV serologic markers
20. Hepatitis B virus infection in patients with idiopathic liver disease
21. Avoiding false positives with PCR
22. Shedding light on PCR contamination
23. Confirmation of hepatitis C virus infection by new four‐antigen recombinant immunoblot assay
24. Detection of hepatitis C virus RNA by a two‐stage polymerase chain reaction with two pairs of primers deduced from the 5′ noncoding region
25. Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C
26. Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay
27. Use of conserved sequences from hepatitis C virus for the detection of viral RNA in infected sera by polymerase chain reaction
28. Latent hepatitis B virus infection in a patient serologically immune to hepatitis B virus infection
29. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen
30. Identification of integrated hepatitis B virus DNA sequences in human hepatocellular carcinoma
31. HBV‐DNA sequences are rarely detected in the liver of patients with HBsAg‐negative chronic active liver disease and with hepatocellular carcinoma
32. Expression of the hepatitis B virus genome in chronic hepatitis B carriers and patients with hepatocellular carcinoma
33. Hepatocellular carcinoma in alcoholic liver disease: no evidence for a pathogenetic role of hepatitis B virus infection
34. Identification and characterization of intrahepatic hepatitis B virus DNA in HBsAg‐seronegative patients with chronic liver disease and hepatocellular carcinoma in Taiwan
35. Evidence for supercoiled hepatitis B virus DNA in chimpanzee liver and serum Dane particles: possible implications in persistent HBV infection
36. Hepatocellular carcinoma and the hepaititis B virus
37. Hepatocellular carcinoma in woodchuck hepatitis virus infected woodchucks: presence of viral DNA in tumor tissue from chronic carriers of animals serologically recovered from acute infections
38. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma: studies in percutaneous liver biopsies and post‐mortem tissue specimens
39. The hepatitis B virus
40. The molecular genetics of cancer
41. The oncogenic potential of herpes simplex viruses: evidence for a “hit and run” mechanism
42. Human papillomavirus type 6b DNA is required for initiation but not maintenance of transformation of C127 mouse cells
43. Detection of chronic hepatitis C virus infection by four diagnostic systems: first‐generation and second‐generation enzyme‐linked immunosorbent assay, second‐generation recombinant immunoblot assay and nested polymerase chain reaction analysis
44. Sensitivity of serological assays to identify blood donors with hepatitis C viraemia
45. Detection of replicative hepatitis C virus sequences in hepatocellular carcinoma
46. Non‐A, non‐B chronic hepatitis is chronic hepatitis C: a sensitive assay for detection of hepatitis C virus RNA in the liver
47. Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs
48. Maternal‐infant transmission of hepatitis C virus and HIV infections: a possible interaction
49. Transmission of hepatitis C virus
50. Risk for non‐A, non‐B (type C) hepatitis through sexual or household contact with chronic carriers
51. Molecular biology of hepatitis C viruses: implications for diagnosis, development and control of viral disease
52. Detection of hepatitis C virus cDNA sequence by polymerase chain reaction in hepatocellular carcinoma tissues
53. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B
54. Interference between non‐A, non‐B and hepatitis B virus infection in chimpanzees
55. Non‐A, non‐B hepatitis in chimpanzees: interference with acute hepatitis A virus and chronic hepatitis B virus infections
56. Delta hepatitis and the hepatitis delta virus